CRP | No CRP | p | |
---|---|---|---|
Number of patients (%) | 111/220 (50) | 109/220 (50) | 0.9 |
Female, n (%) | 71/111 (64) | 70/109 (64) | 1 |
Age, years, median (IQR) | 35 (26–39) | 31 (21–38) | 0.02a |
Days with symptoms, median (IQR) | 4 (3–7) | 3 (2–6) | 0.01a |
Tested with a RADT for GAS, n (%) | 108/111 (97) | 99/109 (91) | 0.04 |
Positive RADT, n (% of RADTs) | 26/108 (24) | 42/99 (42) | 0.005 |
Centor score, n (%) | 0.002 | ||
0 | 9/111 (8) | 7/109 (6) | |
1 | 34/111 (31) | 16/109 (15) | |
2 | 37/111 (33) | 32/109 (30) | |
3 | 24/111 (22) | 30/109 (28) | |
4 | 7/111 (6) | 24/109 (22) |